Stonepine Capital Management as of Dec. 31, 2022
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 19 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Plc - Spnr Sponsored Ads | 19.4 | $46M | 6.3M | 7.30 | |
| Apollo Endosurgery | 15.6 | $37M | 3.7M | 9.97 | |
| Cti Biopharma | 12.5 | $30M | 4.9M | 6.01 | |
| Adma Biologics (ADMA) | 11.3 | $27M | 6.9M | 3.88 | |
| Quidel Corp (QDEL) | 10.8 | $26M | 300k | 85.67 | |
| Xeris Pharmaceuticals (XERS) | 6.3 | $15M | 11M | 1.33 | |
| Urogen Pharma (URGN) | 4.9 | $12M | 1.3M | 8.87 | |
| Third Harmonic Bio (THRD) | 3.6 | $8.7M | 2.0M | 4.30 | |
| Galapagos Nv- Spon Adr (GLPG) | 3.6 | $8.6M | 195k | 44.38 | |
| Evolus (EOLS) | 2.6 | $6.3M | 834k | 7.51 | |
| Rezolute Com New (RZLT) | 2.6 | $6.3M | 3.0M | 2.07 | |
| Castle Biosciences (CSTL) | 1.8 | $4.2M | 178k | 23.54 | |
| Conformis | 1.0 | $2.5M | 748k | 3.32 | |
| Mirum Pharmaceuticals (MIRM) | 0.9 | $2.1M | 109k | 19.50 | |
| Exagen (XGN) | 0.9 | $2.0M | 854k | 2.40 | |
| Maxcyte (MXCT) | 0.6 | $1.5M | 273k | 5.46 | |
| Omniab (OABI) | 0.5 | $1.3M | 354k | 3.60 | |
| Xoma Corp Com New (XOMA) | 0.5 | $1.2M | 65k | 18.40 | |
| Optinose (OPTN) | 0.4 | $940k | 508k | 1.85 |
